Characteristics | No. (%) |
---|---|
Sex/male | 33 (58.9) |
Age, mean (range, year) | 64.0 (43–89) |
B symptoms/yes | 36 (64.3) |
Ann Arbor stage | |
II | 3 (5.4) |
III | 25 (44.6) |
IV | 28 (50.0) |
ECOG-PS > 1 | 13 (23.2) |
Elevated LDH | 42 (73.3) |
Elevated β2-MG | 36 (64.3) |
Declined PLT count | 35 (62.5) |
Declined albumin | 41 (73.2) |
BMB positive | 13 (23.2) |
Extranodal involvement/yes | 34 (60.7) |
Extranodal sites > 1/yes | 9 (16.1) |
IPI | |
0–1 | 10 (17.9) |
2–3 | 27 (48.2) |
4–5 | 19 (33.9) |
PIT | |
0 | 10 (17.9) |
1 | 20 (35.7) |
2 | 18 (32.1) |
3 | 5 (8.9) |
4 | 3 (5.4) |